Home > Browse Research > Company Reports > I - Companies

I - Companies: market research reports

Detailed company information is available through Company Reports. These reports will focus on specific organisations and their key markets and competitors. Typically these reports will contain some key facts about the organisation such as the number of employees, products offerings and earnings and revenue information.

Also included will be a SWOT analysis detailing the company’s strengths, weakness, opportunities and treats in the current marketplace.

The reports will often also list the organisations main competitors in the sectors in which they operate.

Companies who name beings with an I, who may be included in the company reports, include :

Illinois Tool Works, , Imperial Chemical Industries, Imperial Oil, Imperial Tobacco Group, IMS Health, Industrial Bank of Japan, Infinity Broadcasting, ING Group, Invensys, Investor AG.

I - Companies market research reports and industry analysis

Invertec Foods S.A. - Company Capsule 5/20/2013 \| published by: Canadean Ltd ... major products and services, financial ratios, key competitors, financial analysis, key employees as well as company locations and subsidiaries. Summary This report is a crucial resource for industry executives and anyone looking to access key ... \| read more...	$99.00
Inrob Tech, Ltd.: Defense - Company Profile & SWOT Report 5/20/2013 \| published by: Strategic Defence Intelligence ... its operations. The profile contains a company overview, key facts, major products and services, swot analysis, business description, company history, mergers & acquisitions, key employees as well as employee biographies. Summary This report is a ... \| read more...	$125.00
Investment Commerce Fisheries Corporation - Company Capsule 5/19/2013 \| published by: Canadean Ltd ... key facts, major products and services, financial ratios, financial analysis, key employees, company locations and subsidiaries. Summary This report is a crucial resource for industry executives and anyone looking to access key information about Investment ... \| read more...	$99.00
Internacional de Ceramica, S.A. de C.V. - Company Capsule 5/19/2013 \| published by: Canadean Ltd ... contains a company overview, key facts, major products and services, financial ratios, key competitors, financial analysis, key employees as well as company locations and subsidiaries. Summary This report is a crucial resource for industry executives ... \| read more...	$99.00
Indara Insurance Public Company Limited (INSURE) : Company Profile and SWOT Analysis 5/16/2013 \| published by: World Market Intelligence ... business description, financial ratios, SWOT analysis, key competitors, key facts, key employees as well as information on products and services. Summary This SWOT analysis and company profile is a crucial resource for industry executives and ... \| read more...	$120.00
Infusion Brands International, Inc. - Company Capsule 5/16/2013 \| published by: Canadean Ltd ... key facts, major products and services, financial ratios, key competitors, financial analysis as well as key employees. Summary This report is a crucial resource for industry executives and anyone looking to access key information about ... \| read more...	$99.00
Islamic Arab Insurance Company (PSC) (SALAMA) : Company Profile and SWOT Analysis 5/16/2013 \| published by: World Market Intelligence ... business description, financial ratios, SWOT analysis, key competitors, key facts, key employees, locations and subsidiaries as well as information on products and services. Summary This SWOT analysis and company profile is a crucial resource for ... \| read more...	$120.00
ImmunoCellular Therapeutics, Ltd. (IMUC) - Product Pipeline Analysis, 2013 Update 5/9/2013 \| published by: GlobalData ... company’s immunotherapies product pipeline comprises ICT-140, ICT-121 and ICT-107. ICT-140 is a DC vaccine designed to target seven different ovarian cancer antigens. ICT-121, is being developed for the treatment of solid tumors and ICT-107 is ... \| read more...	$750.00
InSightec Ltd. - Product Pipeline Analysis, 2013 Update 5/9/2013 \| published by: GlobalData ... integrates ultrasound surgery with continuous magnetic resonance imaging (MRI) to provide a non invasive, acoustic surgery for treating neurological disorders. InSightec’s system components include patient table, ergonomic cradle, cradle storage and replacement rack, operator console, ... \| read more...	$750.00
Insulet Corporation (PODD) - Product Pipeline Analysis, 2013 Update 5/9/2013 \| published by: GlobalData ... disposable insulin infusion device and the Personal Diabetes Manager, a handheld device. The company along with its subsidiary, Neighborhood Diabetes, offers blood glucose testing supplies, insulin pumps, pharmaceuticals and pump supplies. The company has distribution ... \| read more...	$750.00
Innocoll Technologies Ltd - Product Pipeline Analysis, 2013 Update 5/9/2013 \| published by: GlobalData ... durieva. The company’s approved products include zorprevasurgical haemostat, collacare family, gentamicin surgical implant, collexa, lidocoll, collaguard adhesion barrier and innocoll dental. Its products are developed using its technologies namely CollaRx and Liquicoll. Innocoll Technologies products ... \| read more...	$750.00
InsightMRI - Product Pipeline Analysis, 2013 Update 5/9/2013 \| published by: GlobalData ... and the insight knee coil. InsightMRI’s customers include hospitals, clinics, surgery centers, physician offices, nursing homes, long-term care facilities, home healthcare, and retail healthcare. The company develops MRI electronics and apparatus for both clinical and ... \| read more...	$750.00
ImmunoCellular Therapeutics, Ltd. (IMUC) - Financial and Strategic SWOT Analysis Review 5/7/2013 \| published by: GlobalData ... company’s immunotherapies product pipeline comprises ICT-140, ICT-121 and ICT-107. ICT-140 is a DC vaccine designed to target seven different ovarian cancer antigens. ICT-121, is being developed for the treatment of solid tumors and ICT-107 is ... \| read more...	$125.00
Interconexion Electrica S.A. E.S.P. (ISA) - Financial and Strategic SWOT Analysis Review 5/7/2013 \| published by: GlobalData ... time systems and road concessions. It operates a network of 40,665 km of high voltage circuits. The company also focuses on the transport of telecommunication signals through its subsidiary, Internexa. Besides, ISA carries out construction ... \| read more...	$125.00
Ipsen Biopharmaceuticals, Inc. - Strategic SWOT Analysis Review 5/7/2013 \| published by: GlobalData ... for the treatment of children suffering from short stature due to severe primary IGFD; Somatuline Depot (lanreotide) injection, used to treat acromegaly; and Dysport (abobotulinumtoxinA injection), developed for the treatment of cervical dystonia. Ipsen manages ... \| read more...	$125.00
Imdex Limited (IMD) - Financial and Strategic SWOT Analysis Review 5/7/2013 \| published by: GlobalData ... horizontal directional drilling and civil industries. It also provides advanced down hole survey, core orientation, and directional steering instrumentation services for the exploration and mining companies. Imdex operates through two reportable business segments, namely, Minerals ... \| read more...	$125.00
Ittehad Chemicals Limited (ICL) - Financial and Strategic SWOT Analysis Review 5/7/2013 \| published by: GlobalData ... are hydrochloric acid, sodium hypochlorite, liquid chlorine, bleaching earth, chlorinated paraffin, sulphuric acid, zinc sulphate, and barium sulphate, as well as caustic soda. The products manufactured by the company find applications in wide range of ... \| read more...	$125.00
Idenix Pharmaceuticals, Inc. (IDIX) - Financial and Strategic SWOT Analysis Review 5/3/2013 \| published by: GlobalData ... treating infections caused by hepatitis C virus (HCV). The company co-developed Tyzeka/Sebivo with Novartis AG for the treatment of chronic hepatitis B. Its pipeline products include IDX899 for the treatment of HIV/AIDS, and IDX375 for ... \| read more...	$125.00
INA - Industrija nafte d.d. (INA-R-A) - Financial and Strategic SWOT Analysis Review 5/3/2013 \| published by: GlobalData ... and services through three core reportable business segments namely, Exploration & Production; Refining and Marketing; and Retail. It explores for, develops and produces oil and natural gas in offshore and onshore assets located in Croatia, ... \| read more...	$125.00
Inovio Pharmaceuticals, Inc. (INO) - Financial and Strategic SWOT Analysis Review 5/3/2013 \| published by: GlobalData ... universal immune responses against multiple known and newly emergent unmatched strains of pathogens such as influenza. The company’s clinical programs include Phase II studies for leukemia, hepatitis C virus and cervical dysplasia; and Phase I ... \| read more...	$125.00
Isotechnika Pharma Inc. (ISA) - Financial and Strategic SWOT Analysis Review 5/3/2013 \| published by: GlobalData ... company's lead product is a next generation calcineurin inhibitor, which has completed a Phase IIb kidney transplant trial. The drug has been developed for various indications such as chronic plaque psoriasis and kidney transplantation. Isotechnika ... \| read more...	$125.00
Idera Pharmaceuticals, Inc. (IDRA) - Financial and Strategic SWOT Analysis Review 5/3/2013 \| published by: GlobalData ... that are targeted to Toll-Like Receptors (TLR) for treatment of infectious diseases and which can be used as vaccine adjuvants. The company designs and formulates proprietary TLR agonists and antagonists to modulate immune responses. The ... \| read more...	$125.00
Integra LifeSciences Holdings Corporation (IART) - Financial and Strategic SWOT Analysis Review 5/3/2013 \| published by: GlobalData ... tissue-engineered wound dressings and nerve and tendon repair products. Its neurosurgery products consist of dural grafts, ultrasonic surgery systems, systems for measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. The ... \| read more...	$125.00
ImmunoGen, Inc. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ImmunoGen, Inc.’s corporate ... \| read more...	$1,500.00
Isis Pharmaceuticals, Inc. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ... \| read more...	$1,500.00

< prev 1 2 3 4 5 6 7 8 9 10 next >